ClinicalTrials.gov
public full text
Public Domain
A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema
The goal of this trial is to enable the collection of information about long-term safety and clinical activity of STAR-0215 in participants with hereditary angioedema (HAE). Participants will receive repeat doses of STAR-0215 for up to 5 years.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase 2 in Adult Subjects With Hereditary Angioedema#903473
- The Neglected Older Adults in Hereditary Angioedema: Insights From the ITACA Registry.#265672
- NTLA-2002 in Adults With Hereditary Angioedema (HAE)#880335
- ANGiographic Evaluation of Left Main Coronary Artery INtErvention#899773
- Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia#862119
Record · ID 1186264
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive